Medopharm Pharmaceutical Company
Medopharm is one of the leading pharmaceutical export manufacturing company in India.
In about 50 years, Medopharm has substantially abridged its pharmaceutical products portfolio to over 100 products while starting with just 2 products in 1970. The accelerated growth was achieved through in-house development and strategic in-licensing. Concentrating our efforts on a wide range of products that cover a variety of therapeutic areas and dosage forms, Medopharm always made a choice to manufacture affordable medicines for patients. Our basket of pharmaceutical products encompasses tablets, capsules, oral suspensions, and solutions.
What We Offer for You
Medopharm is one of the leading manufacturers and exporters of pharmaceutical products in India.
Medopharm management practices are aligned towards ensuring the safe and secure manufacture of pharmaceutical products with high standards.
Medopharm’s Quality Management System is aligned with the international quality guidelines. We ensure full compliance with applicable regulations.
Medopharm operates on a futuristic outlook that has a structured customer complaint redressal system for prompt and quick
We believe that the key to quality management is consistent inspection at every stage, from procurement, manufacturing, to the delivery of finished goods.
Our Business Associates
Our success over the years
Medopharm Manufacturing Facilities
Medopharm currently has two manufacturing facilities at Chennai and Malur for finished formulations of generics and branded generic products. We also have a new manufacturing facility coming up adjacent to the Chennai plant. This facility will augment our manufacturing capability substantially.
As Medopharm is an environmentally conscious company, we are continuously keeping close tabs on all our production lines to ensure that our operations and by-products do not damage the fragile ecosystem.
All of Medopharm’s facilities are engineered to handle waste and minimize pollution as well as environmental contamination. The cleanliness and safety of the environment are amongst our top priorities.
Chennai Plant - I
Medopharm’s manufacturing unit located in Chennai is a dedicated Betalactum facility. The unit manufacture finished dosage forms (tablets, capsules, dry powder ) for its own marketing as generics and branded generics, contract manufacturing for third parties, and co-marketing. The state-of-the-art manufacturing facility was approved in 2007 by the Medicines and Healthcare Regulatory Agency (MHRA) of the United Kingdom (UK), United Nations Children’s Fund (UNICEF) besides being WHO cGMP-certified and is also approved by several reputed pharmaceutical companies/clients in India and abroad.
Chennai Plant - II
This unit, Medopharm Private Limited (Unit II), a General formulation unit at 50, Kayarembedu Village, Guduvanchery, Tamil Nadu, India, was commissioned in 2015 and proposed to cater to European/WHO and other third world countries. The total site area is about 17 acres, surrounded by environment-friendly open lands and greenery. The main production block has a total plinth area of about 42,814 sq. ft(3941 sq. meters). meters. The second block houses utilities on the ground floor and QC Lab on the first floor, a combined plinth area of about 800 sqm.
Medopharm Private Limited (Unit II) site is a new proposed Solid Oral Dosage Formulations manufacturing unit for production of Tablets & Capsules formulations in generics & branded generics, for domestic as well as exports to other countries for its own marketing, contract manufacturing for third parties and co-marketing.
Medopharm’s manufacturing unit located in Bangalore is spread over 2 acres with a total production area of 2,100 square metres. The unit manufactures finished dosage forms (tablets, capsules and dry powder) for its own marketing as generics and branded generics, contract manufacturing for third parties and co-marketing. The state-of-the art manufacturing facility in Bangalore is WHO cGMP-certified and is also approved by several reputed pharmaceutical companies/clients in India and abroad. The annual production capacity is 6000 million units of tablets, 200 million units of capsules on 2 shift basis. It was upgraded in 2000 and 2005.
Meet Our Team
“We were most impressed with the professionalism at Medopharm and it was a real pleasure to work with them. Considering the fact that I handle several countries, I needed a contract manufacturer who can offer an end-to-end solution.”
“Thank you for all your support and let’s keep rolling our good collaboration.”
“Partnering with Medopharm, a Beta-lactam facility pharma manufacturer has really added great value to us. We were surprised by their pharmaceutical expertise and the swift responsive action of their team.”
“Our collaboration with Medopharm has grown exponentially over the years.”